GLP-1 receptors are distributed not only in the pancreas and brain but also in the cardiovascular system, kidneys, and gastrointestinal tract
Since the first-line intervention for obesity is typically lifestyle change(s) 4 , this study purposefully combined LD switch with 5A-1MQ treatment
The Bottom Line GLP-1 receptor agonist medications are changing lives for many people, but they also change the way the digestive system works and, for many users, reduce the dietary fiber and nutrient diversity that a healthy gut microbiome depends on
Gallbladder disease and risk of type 2 diabetes in postmenopausal women: a womens health initiative study
A very interesting epidemiological study that supports this idea showed that in normal subjects, IGF-1 contributes to glucose homeostasis
Your Precision Peptide Genetic Test results guide which option best matches your neurobiology, ensuring you find an effective, well-tolerated medication